HepG2 | | ![EXOSC10-HEPG2-CRISPR-A303-987A.png<br>Caption: Western blot following CRISPR against EXOSC10 in HepG2 whole cell lysate using EXOSC10 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against EXOSC10. EXOSC10 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.](https://graveleylab.cam.uchc.edu/ENCODE/ENCODE_DATA/WesternBlot/EXOSC10-HEPG2-CRISPR-A303-987A.png)
Caption: Western blot following CRISPR against EXOSC10 in HepG2 whole cell lysate using EXOSC10 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against EXOSC10. EXOSC10 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. Releated Sample: BGHcLV22-23 Status: Released Lab: Graveley Lab |
---|
K562 | ![Bethyl_A303-987A_1_EXOSC10.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the EXOSC10 specific antibody, A303-987A. Lanes 1 and 3 are 2.5% of five million whole cell lysate input. Lanes 2 and 4 are 50% of IP enrichment from five million whole cell lysate using normal IgG antibody and the EXOSC10-specific antibody, A303-987A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.](https://graveleylab.cam.uchc.edu/ENCODE/ENCODE_DATA/WesternBlot_primary/Bethyl_A303-987A_1_EXOSC10.png)
Caption: IP-WB analysis of K562 whole cell lysate using the EXOSC10 specific antibody, A303-987A. Lanes 1 and 3 are 2.5% of five million whole cell lysate input. Lanes 2 and 4 are 50% of IP enrichment from five million whole cell lysate using normal IgG antibody and the EXOSC10-specific antibody, A303-987A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used. Method: immunoprecipitation Releated Sample: eCLIP:4161 Status: Released Lab: Yeo Lab | ![EXOSC10-K562-CRISPR-A303-987A.png<br>Caption: Western blot following CRISPR against EXOSC10 in K562 whole cell lysate using EXOSC10 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against EXOSC10. EXOSC10 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.](https://graveleylab.cam.uchc.edu/ENCODE/ENCODE_DATA/WesternBlot/EXOSC10-K562-CRISPR-A303-987A.png)
Caption: Western blot following CRISPR against EXOSC10 in K562 whole cell lysate using EXOSC10 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against EXOSC10. EXOSC10 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. Releated Sample: BGKcLV21-21 Status: Released Lab: Graveley Lab |
---|